Detailed examinations of the biological changes caused by SGLT2 mutations revealed that SGLT2 not only serves as a target for diabetes treatment through its function in glucose reabsorption in the kidney but is also associated with bone metabolism, life span, and brain function. This evidence concerns the gene SLC5A2 and diabetes mellitus.